Dashboard
Manage Tickers

EQEquillium, Inc.


$ 1.69 $ -0.10 (-5.52 %)    

Friday, 26-Apr-2024 15:58:44 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ na
$ 1.70
$ 0.00 x 0
$ 0.00 x 0
$ 1.69 - $ 1.70
$ 0.45 - $ 3.25
80,229
na
59.38M
$ 0.83
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-maintains-buy-on-equillium-raises-price-target-to-5
HC Wainwright & Co. Maintains Buy on Equil...
04/02/2024 12:55:37

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Equillium (NASDAQ:EQ) with a Buy and raises the price target fr...

why-westport-fuel-systems-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Westport Fuel Systems Shares Are Tradi...
03/26/2024 17:45:27

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected ...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
03/26/2024 17:31:10

equillium-q4-earnings-insights
Equillium: Q4 Earnings Insights
03/25/2024 21:35:06

equillium-q4-2023-gaap-eps-007-beats-017-estimate-sales-9200m-beat-6425m-estimate
Equillium Q4 2023 GAAP EPS $(0.07) Beats $...
03/25/2024 20:02:25

Equillium (NASDAQ:EQ) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.17) by 58...

on-february-21-2024-equillium-received-a-letter-from-the-listing-qualifications-department-of-the-nasdaq-stock-market-notifying-the-company-that-it-has-regained-compliance-with-the-listing-requirement-8k
On February 21, 2024, Equillium Received A...
02/22/2024 11:12:54

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
02/19/2024 17:30:50

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
02/16/2024 21:31:07

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
02/06/2024 17:31:29

cognizant-technology-solutions-to-rally-over-13-here-are-10-top-analyst-forecasts-for-tuesday
Cognizant Technology Solutions To Rally Ov...
12/26/2023 13:03:37

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

hc-wainwright--co-maintains-buy-on-equillium-lowers-price-target-to-4
HC Wainwright & Co. Maintains Buy on Equil...
12/26/2023 11:22:43

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Equillium (NASDAQ:EQ) with a Buy and lowers the price target fr...

equillium-announces-update-on-multi-cytokine-inhibitors-eq101--eq102-in-development-for-alopecia-areata-and-celiac-disease
Equillium Announces Update On Multi-Cytoki...
12/21/2023 13:09:26

EQ101 Phase 2 study in alopecia areata is fully enrolled with topline data expected in Q2 2024EQ302, an orally delivered multi-...

hc-wainwright--co-maintains-buy-on-equillium-lowers-price-target-to-45
HC Wainwright & Co. Maintains Buy on Equil...
11/13/2023 16:25:02

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Equillium (NASDAQ:EQ) with a Buy and lowers the price target fr...

equillium-presents-data-from-phase-1b-equalise-study-at-the-2023-annual-meeting-of-the-american-college-of-rheumatology
Equillium Presents Data From Phase 1b EQUA...
11/13/2023 14:06:45

Itolizumab continues to show clinically meaningful response in highly proteinuric subjectsAt Week 28, 73% of subjects achieved ...

equillium-q3-eps-011-beats-021-estimate-sales-887m-beat-800m-estimate
Equillium Q3 EPS $(0.11) Beats $(0.21) Est...
11/08/2023 21:55:41

Equillium (NASDAQ:EQ) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.21) by 47...

equillium-announces-data-from-phase-1b-equalise-study-was-presented-at-2023-annual-meeting-of-the-american-society-of-nephrology
Equillium Announces Data From Phase 1b EQU...
11/06/2023 13:14:36

Itolizumab continues to show clinically meaningful response in highly proteinuric subjectsAt Week 28, 73% of subjects achieved ...

equillium-announces-preclinical-data-from-new-orally-deliverable-multi-cytokine-inhibitor-in-presentation-at-the-18th-annual-peptide-therapeutics-symposium
Equillium Announces Preclinical Data From ...
10/16/2023 12:16:40

Equillium Inc. (NASDAQ:EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe aut...

cantor-fitzgerald-reiterates-overweight-on-equillium-maintains-28-price-target
Cantor Fitzgerald Reiterates Overweight on...
08/14/2023 12:54:11

Cantor Fitzgerald analyst Emma Nealon reiterates Equillium (NASDAQ:EQ) with a Overweight and maintains $2.8 price target.

hc-wainwright--co-reiterates-buy-on-equillium-maintains-55-price-target
HC Wainwright & Co. Reiterates Buy on Equi...
08/14/2023 10:24:16

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Equillium (NASDAQ:EQ) with a Buy and maintains $5.5 price target.

equillium-q2-eps-010-beats-021-estimate-sales-912m-beat-800m-estimate
Equillium Q2 EPS $(0.10) Beats $(0.21) Est...
08/09/2023 20:41:28

Equillium (NASDAQ:EQ) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.21) by 52...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION